Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation.
作者信息
Mohan Vivek, Jain Sachin, Naithani Rahul
机构信息
Department of Hematology and Bone Marrow Transplant, Paras Health, Gurugram, Haryana, India.